[Mass spectrometry application for clinical diagnostics chairmen's introductory remarks]

Kuniaki Saito, Fumio Nomura

研究成果: Review article査読

抄録

Mass spectrometry has been recently used in clinical diagnostics, especially drug screening, newborn screening, and bacterial identification; therefore, the current developments in mass spectrometry platforms (i. e. GC-MS, LC-MS/MS) and applications for clinical diagnosis will be discussed. Technological advances in drug analyses and bacterial identification using mass spectrometry during recent years have provided an effective tool for the clinical laboratory. This symposium provides a comprehensive future overview of the latest technologies to quantify metabolites, drugs, and identify bacterial proteins using mass spectrometry, proposed for potential new biomarker development.

本文言語English
ページ(範囲)803-804
ページ数2
ジャーナルRinsho byori. The Japanese journal of clinical pathology
61
9
出版ステータスPublished - 01-09-2013
外部発表はい

All Science Journal Classification (ASJC) codes

  • Medicine(all)

フィンガープリント 「[Mass spectrometry application for clinical diagnostics chairmen's introductory remarks]」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル